Five Things Going Right: September 9, 2026

Five real advances in science, medicine, technology, and the environment, each verified against the original reporting. In this episode: A new pancreatic cancer drug has doubled lifespan for late-stage patients and received immediate FDA approval; A new method (S-DEIM) estimates sea surface temperatures 40% more accurately than conventional approaches and; Researchers from Kyoto University developed a rational method for designing defined microbial communities; A decade-long randomized trial found that implantable cardioverter-defibrillators may benefit patients under; A study of 25 Black women found that racialized bias in childhood classrooms has lasting negative effects on. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.goodnewsnetwork.org/fda-immediately-approves-drug-thats-doubling-lifespan-for-late-pancreatic-cancer-patients/ https://phys.org/news/2026-09-sparse-method-sea-surface-temperatures.html https://phys.org/news/2026-09-optimizing-tomato-growth-microbes.html https://scitechdaily.com/cardiac-breakthrough-could-offer-lifesaving-treatment-to-more-patients/ https://phys.org/news/2026-09-classrooms-careers-black-women-effects.html